Progression of sarcopenia among patients with pancreatic ductal adenocarcinoma receiving neoadjuvant therapy and the impact of pancreatic enzyme replacement therapy
Progression of sarcopenia among patients with pancreatic ductal adenocarcinoma receiving neoadjuvant therapy and the impact of pancreatic enzyme replacement therapy. // Hepatobiliary & Pancreatic Diseases International. – URL: https://www.sciencedirect.com/science/article/pii/S1499387226001141?dgcid=rss_sd_all
Progression of sarcopenia among patients with pancreatic ductal adenocarcinoma receiving neoadjuvant therapy and the impact of pancreatic enzyme replacement therapy. Hepatobiliary & Pancreatic Diseases International. https://www.sciencedirect.com/science/article/pii/S1499387226001141?dgcid=rss_sd_all
“Progression of sarcopenia among patients with pancreatic ductal adenocarcinoma receiving neoadjuvant therapy and the impact of pancreatic enzyme replacement therapy.” Hepatobiliary & Pancreatic Diseases International.
@article{article48044,
title = {Progression of sarcopenia among patients with pancreatic ductal adenocarcinoma receiving neoadjuvant therapy and the impact of pancreatic enzyme replacement therapy},
journal = {Hepatobiliary \& Pancreatic Diseases International},
url = {https://www.sciencedirect.com/science/article/pii/S1499387226001141?dgcid=rss_sd_all}
}